A major advance in cancer investigation is arising with the use of mini-antibodies to restore mutated p53. This vital malignant inhibitor protein is frequently inactivated in several forms of tumors, causing https://mirrorbookmarks.com/story21849726/vhh-fragments-revive-p53-the-potential-approach-for-tumor-management